Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Hanesbrands

How to Trade These 3 Stocks That Just Flashed the ‘Death Cross’

While the technical pattern sounds incredibly ominous, the slowing of momentum could represent an opportunity to trade with the current.

Workers' rights groups pursue Specialized for portion of $650K unpaid wages and benefits to factory workers

Workers' rights groups pursue Specialized for portion of $650K unpaid wages and benefits to factory workers

Worker Rights Consortium urges 'Specialized to make meaningful contributions to address the outstanding arrears to the workers who made their branded apparel at the APS factory'

Investors Need to Think Very Carefully Before Buying the Hanesbrands (HBI) Rumor

Investors Need to Think Very Carefully Before Buying the Hanesbrands (HBI) Rumor

With Hanesbrands the subject of a possible targeting by an activist investor, HBI stock soared. But even if the rumor turns out to be true, it’s not a confidence-inspiring wager.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Around $17 Million Bet On This Healthcare Stock? 4 Stocks Insiders Are Buying

Although US stocks closed higher on Thursday, there were a few notable insider trades.

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

Wolverine Worldwide Sells Champion Trademarks To HanesBrands For $90M Cash

Wolverine World Wide Inc (NYSE:WWW) subsidiary, Keds LLC, has sold Champion trademarks for footwear in the U.S. and Canada to its longtime licensee, HanesBrands Inc (NYSE:HBI), for $90 million in cash. Under the agreement, Wolverine Worldwide will retain a perpetual license to continue using the Champion trademark on certain footwear, including the Keds Champion sneaker.…

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

6 Analysts Have This to Say About Hanesbrands

6 Analysts Have This to Say About Hanesbrands

Over the past 3 months, 6 analysts have published their opinion on Hanesbrands (NYSE:HBI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022

5 Value Stocks To Watch In The Consumer Cyclical Sector

5 Value Stocks To Watch In The Consumer Cyclical Sector

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Hanesbrands's Return on Invested Capital Insights

Hanesbrands's Return on Invested Capital Insights

According to Benzinga Pro, during Q1, Hanesbrands (NYSE:HBI) earned $118.70 million, a 97.73% increase from the preceding quarter. Hanesbrands's sales decreased to $1.58 billion, a 10.05% change since Q4.

5 Analysts Have This to Say About Hanesbrands

5 Analysts Have This to Say About Hanesbrands

Hanesbrands (NYSE:HBI) has observed the following analyst ratings within the last quarter:

Is Hanesbrands a Good High-Yield Dividend Stock to Invest In?

Is Hanesbrands a Good High-Yield Dividend Stock to Invest In?

The iconic apparel brand marketer Hanesbrands Inc. (HBI) posted solid sales and earnings growth in its last reported quarter, led by year-over-year improvement in segmental revenue. In addition, the company declared a regular cash dividend of 0.15. The stock delivers a 4.8% dividend yield currently. But is it worth adding…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Hanesbrands Shares Slide Post Q1 Results; Eyes Low-End Of FY22 EPS Outlook

Hanesbrands Inc (NYSE:HBI) reported first-quarter FY22 sales growth of 5% year-on-year to $1.58 billion, beating the consensus of $1.54 billion. Consumer demand for the company's brands drove growth in the U.S., Americas, and Europe. Innerwear sales increased 1.5% Y/Y due to retail space gains, a positive mix benefit, and the partial-quarter benefit of…

Hanesbrands: Q1 Earnings Insights

Hanesbrands (NYSE:HBI) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Hanesbrands And 2 Other Stocks Bought By Insiders

US stock futures traded lower this morning after recording sharp losses in the previous session. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Hanesbrands: Q4 Earnings Insights

Hanesbrands (NYSE:HBI) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Organisations

Advanced Micro Devices

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

262,833 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play